Alerts will be sent to your verified email
Verify Email
ANG
|
ANG Lifesciences
|
Medistep Healthcare
|
JFL Life Sciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
3.78 % | 24.77 % | 12.26 % |
|
5yr average Equity Multiplier
|
3.3 | 1.32 | 2.68 |
|
5yr Average Asset Turnover Ratio
|
0.77 | 2.13 | 0.93 |
|
5yr Avg Net Profit Margin
|
-2.26 % | 8.79 % | 5.75 % |
|
Price to Book
|
0.56 | 1.9 | 0.81 |
|
P/E
|
0.0 | 7.8 | 7.15 |
|
5yr Avg Cash Conversion Cycle
|
70.26 Days | 115.71 Days | 138.58 Days |
|
Inventory Days
|
107.37 Days | 9.08 Days | 96.42 Days |
|
Days Receivable
|
274.82 Days | 124.47 Days | 135.23 Days |
|
Days Payable
|
235.98 Days | 17.5 Days | 103.44 Days |
|
5yr Average Interest Coverage Ratio
|
1.81 | 96.98 | 4.03 |
|
5yr Avg ROCE
|
15.08 % | 33.38 % | 17.72 % |
|
5yr Avg Operating Profit Margin
|
7.68 % | 11.92 % | 10.31 % |
|
5 yr average Debt to Equity
|
0.97 | 0.04 | 0.9 |
|
5yr CAGR Net Profit
|
n/a | 35.1 % | 50.43 % |
|
5yr Average Return on Assets
|
1.04 % | 18.77 % | 5.01 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
70.6 % | 68.96 % | 67.47 % |
|
Share Pledged by Promoters
|
44.88 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.55 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
ANG Lifesciences
|
Medistep Healthcare
|
JFL Life Sciences
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|